Researchers designed a new nanoparticle adjuvant that may be more potent than others now in use. Studies in mice showed it significantly improved antibody production following vaccination against HIV, diphtheria and influenza.
from Top Health News -- ScienceDaily https://ift.tt/3xSdP9b
Subscribe to:
Post Comments (Atom)
Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO
However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...
-
Solar cells made of perovskite hold much promise for the future of solar energy. However, the material degrades quickly, severely limiting i...
-
With 73,642 new daily recoveries, the most so far, India's recovery rate has improved to 77.32%, while death rate has come down to 1.72%...
-
Although organ failure can be fatal, your kidneys, heart, and liver are prepared for this catastrophe. Emerging research supports the findin...
No comments:
Post a Comment